Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.
A recent study of Dutch clinicians found that they generally did a good job of preventing drug-drug interactions.
These include a low CD4 count, having cirrhosis and taking certain hep C drug regimens.
Researchers identified this association after looking at real-world data on a large group of German individuals with HIV and hep C.
Such generic drugs could save nations huge sums in the coming years.
The regimen has been well-studied in combination with numerous HIV antiretrovirals (ARVs).
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.